ALXO

Alx Oncology Holdings  (ALXO)

US
$ 1.3125.96%

Price Chart

Key Statistics

Market Cap
$ 28.45M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
13.13M
52W High
$ 17.82
52W Low
$ 0.46
Dividend Yield
0.00%
Beta
1.20

Technicals

50-Day MA
0.7337
200-Day MA
1.7418
52 Week High
17.825
52 Week Low
0.46

About ALXO

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.

Employees
80
Headquarters
South San Francisco, CA
CEO
Mr. Jason W. Lettmann

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg